Scienture (SCNX) reported Thursday the start of commercial sales and fulfillment of the first customer orders for an Arbli (losartan potassium) oral suspension, 10 milligrams per milliliter.

Shares more than doubled as intraday trading volume catapulted to over 575 million from a daily average of about 2.2 million.

Ventyx Biosciences (VTYX) shares soared 91% amid heavy trading after the company overnight said VTX3232 demonstrated significant reductions in cardiovascular risk factors in a trial in phase 2 in patients with obesity and cardiovascular risks.

Intraday trading volume soared to over 103 million shares from a daily average of roughly 1.3 million.

Garrett Motion (GTX) reported stronger-than-expected Q3 earnings and net sales and raised its cash dividend while adjusting full-year 2025 revenue guidance.

Shares jumped 21%, with more than 4.9 million intraday trading volume compared with a daily average of about 3.2 million.

Price: 1.35, Change: +0.77, Percent Change: +135.35